Operator: Thank you for standing by. Welcome to the Atreca s Fourth Quarter and Year End 2022 Earnings Call. At this time, all participants are in a listen-only mode.
Operator: Thank you for standing by. This is the conference operator. Welcome to X4 Pharmaceuticals Fourth Quarter and Full Year 2022 Earnings Conference Call.
World's first Smartphone based offline AI expands geographical scope to deliver convenience and increase access to DR screening. BANGALORE, India, Feb. 23, 2023 /PRNewswire/ Remidio
/PRNewswire/ Remidio has received CE mark approval for its Medios AI, to detect Referable DR. This approval closely follows the nod the AI received from.